News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News TVT 2020 Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes L.A. McKeown June 19, 2020
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
News Conference News TVT 2019 What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches? Michael O'Riordan June 14, 2019
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
Presentation TVT 2016 Study Design for the PARTNER 3 Low-Risk Trial Presenter: Martin B. Leon June 16, 2016
Presentation TVT 2016 Study Design for the EVOLUT R Low-Risk Trial Presenter: Jeffrey J. Popma June 16, 2016
Presentation TVT 2016 Updates From NOTION: The First All-Comer TAVR Trial Presenter: Lars Sondergaard June 16, 2016